Mental Disorders: all 2,148 studies
Page 21 of 22. Open to participants first (425), then studies with results posted, then the rest; newest registration first within each.
- Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset PsychosisStatus unknownNCT00465920Phase 2
- The Effectiveness of Supported Employment for People With Severe Mental Illness: an RCT in Six European CountriesCompletedNCT00461318Not applicable
- Rapid Tranquillization Trial: TREC-India IICompletedNCT00455234Phase 3
- Non-interventional Study of Ziprasidone in the Treatment of Bipolar and Schizoaffective Disorders.CompletedNCT00454883
- Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI)CompletedNCT00453804Phase 4
- Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI)CompletedNCT00453609Phase 4
- Bioequivalence And Effect Of Food And Water On Lamotrigine in Healthy VolunteersCompletedNCT00449774Phase 1
- Dose Finding of Quetiapine Fumarate 200mg vs 400mg in First Episode PsychosisCompletedNCT00449397Phase 3
- Facilitated Referral for Children Screening Positive for Mental IllnessCompletedNCT00448331
- Integrated Treatment to Persons With Mental Disorders and Co-occurring Substance Use DisordersCompletedNCT00447733Not applicable
- Evaluating the Benefits and Affordability of a Program to Improve the Care of Common Mental Disorders in Primary CareCompletedNCT00446407Not applicable
- Pilot Study of the Feasibility of Palm Pilots in Monitoring Smoking Behavior in Individuals With Chronic Mental IllnessStatus unknownNCT00435903Early Phase 1
- Families Coping With Mental Illness ProgramStatus unknownNCT00435721Phase 1
- Phase III/Seroquel SR Bipolar Depression Monotherapy - USCompletedNCT00422214Phase 3
- Phase 3 /Seroquel SR Acute Mania Monotherapy - USCompletedNCT00422123Phase 3
- A Study of Taurine in Patients With First-episode Psychosis Receiving Antipsychotic TreatmentCompletedNCT00420823Phase 2/3
- Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and AntioxidantsCompletedNCT00419146Phase 2/3
- Study to Compare Two Formulations of Lamotrigine in Healthy SubjectsCompletedNCT00410371Phase 1
- Overcoming Psychiatric Barriers to the Treatment of Hepatitis CCompletedNCT00407732Not applicable
- Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With SchizophreniaCompletedNCT00407277Not applicable
- Parent Training to Promote Early Identification and Treatment of Childhood Behavioral DisordersCompletedNCT00402857Phase 3
- Structuring the Integration of Care Management Services For Medicaid Enrollees Recipients With Chronic Illness, Substance Abuse Problems and Possible Psychiatric DisordersTerminatedNCT00399373
- Indicated Prevention With Omega-3 Fatty Acids in Adolescents With 'At-Risk-Mental-State' for PsychosisCompletedNCT00396643Phase 4
- Medical Self-Management for Improving Health Behavior Among Individuals in Community Mental Health SettingsCompletedNCT00380536Not applicable
- Treatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of PsychosisCompletedNCT00369239Phase 4
- Cost Effective Treatment for Dually Diagnosed HomelessCompletedNCT00368524Not applicable
- Side Effects of Antipsychotic MedicationsCompletedNCT00363181
- Treating Psychotic Symptoms of Young Individuals Presenting a First Episode of Schizophrenia: Comparison of Two State-of-the-Art InterventionsCompletedNCT00358709Phase 3
- Improving HIV Prevention Skills in People With Serious Mental IllnessesCompletedNCT00356291Phase 2
- Three Year Follow up of a Randomised Controlled Trial (RCT) of an Intervention for Tobacco Dependence Among Those With a Psychotic IllnessCompletedNCT00350493
- Multicomponent Risk Factor Intervention for People With a Severe Mental Illness: a Feasibility StudyCompletedNCT00350311Phase 2
- Promoting Infant Mental Health in Foster CareCompletedNCT00339365Phase 2/3
- A Behavioral Intervention to Improve Work OutcomesCompletedNCT00333658Not applicable
- Modafinil as an Adjunctive on Cognitive Functioning in Patients With SchizophreniaCompletedNCT00314639Phase 1/2
- A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I DisorderCompletedNCT00309686Phase 3
- A Clinical Trial on the Antipsychotic Properties of CannabidiolCompletedNCT00309413Phase 2
- Graduated Recovery Intervention Program for Enhancing Treatment for First-Episode PsychosisCompletedNCT00307216Not applicable
- A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR)CompletedNCT00294008
- Comparing Telepsychiatry and In-person OutcomesCompletedNCT00292058Not applicable
- A Survey Study of the Treatment and Outcome Management in Patients Diagnosed With Alzheimer's DiseaseCompletedNCT00291421
- Enhancing the Prospective Prediction of PsychosisCompletedNCT00291200
- PET Neuroimaging of [11C]MirtazapineCompletedNCT00288782Phase 4
- Study of Amantadine for Weight Stabilization During Olanzapine TreatmentCompletedNCT00287352Phase 1
- Family Perspectives:Treatment of Psychiatric Illnesses With Atypical Long Acting Injectable Antipsychotic MedicationTerminatedNCT00287027
- Effectiveness of Screening and Counselling for Elderly With Psychological ProblemsCompletedNCT00283270Phase 4
- Sarcosine Preventive Therapy for Individuals At High Risk for SchizophreniaWithdrawnNCT00276263Phase 2
- Risperidone LA Heathcare Resource StudyCompletedNCT00272597Phase 4
- CARE Study: Improving Treatment for the Most Severely Ill With SchizophreniaCompletedNCT00272584Phase 4
- Strongest Families (Formerly Family Help Program): Pediatric Disruptive Behaviour DisorderCompletedNCT00267579Phase 2
- Brain Imaging and Mental Disorders of Aging InterventionCompletedNCT00267163Phase 4
- A Study of the Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild, Moderate, or Borderline Mental RetardationCompletedNCT00266552Phase 3
- Nursing Intervention for HIV Regime Adherence Among People With Serious Mental Illness (SMI)CompletedNCT00264823Phase 2
- Trial of Supported Employment Versus USES Supported EmploymentCompletedNCT00261235Not applicable
- Access, Detection and Psychological TreatmentsStatus unknownNCT00260273Not applicable
- Transition Into Primary-care Psychiatry (TIPP)CompletedNCT00260013Phase 2/3
- Combination Of PAXIL Tablet And BenzodiazepinesCompletedNCT00259883Phase 4
- Effects of Pretreatment With Ibuprofen in Post-Electroconvulsive Therapy (ECT) HeadacheWithdrawnNCT00258791Not applicable
- A Prospective Study of Risperdal (Risperidone) for the Treatment of Behavioral Disorder Following Psychological Therapy for Challenging Behavior in Learning Disabled ChildrenCompletedNCT00254930Phase 3
- A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With SchizophreniaCompletedNCT00253136Phase 3
- A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental RetardationCompletedNCT00250354Phase 3
- Re-Entry MTC for Offenders With MICA DisordersCompletedNCT00249756Not applicable
- A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic SchizophreniaCompletedNCT00249223Phase 3
- A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic SchizophreniaCompletedNCT00249132Phase 3
- A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic SchizophreniaCompletedNCT00249119Phase 3
- Tracking Service Use and Outcomes II:First Episode Psychosis and Psychotic Disorders ClinicTerminatedNCT00248027
- A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar DisorderCompletedNCT00240721Phase 3
- A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive ImpairmentCompletedNCT00240695Phase 3
- Recovery Therapy TrialCompletedNCT00239122Not applicable
- Increasing Treatment Adherence in Co-Occurring Psychiatric and Drug Use DisordersCompletedNCT00237822Phase 2
- A Study of the Safety of Risperidone in the Treatment of Children and Adolescents With Conduct and Other Disruptive Behavior DisordersCompletedNCT00236470Phase 3
- A Study of the Efficacy and Safety of Risperidone in the Prevention of Relapse in Children and Adolescents With Conduct and Other Disruptive Behavior DisordersCompletedNCT00236444Phase 3
- Culturally Responsive Person-Centered Care for PsychosisCompletedNCT00231933Phase 1
- Treatment of MDEs During the Course of Psychotic Disorders With DuloxetineCompletedNCT00224302Phase 4
- A Comparative Study of New Medications for Psychosis in AdolescentsCompletedNCT00222495Not applicable
- Effectiveness of Self-Help for Dually-Diagnosed Persons - 1CompletedNCT00218582Phase 1/2
- Divalproex Sodium (Depakote) for Explosive Tempers in Adolescents and AdultsCompletedNCT00218114Phase 3
- A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's DiseaseCompletedNCT00216502Phase 3
- Evaluation of a Health Promotion Intervention for Persons With Mental IllnessCompletedNCT00215189
- A Study to Determine the Efficacy and Safety of 2 Doses of Org 34517 as Adjunctive Therapy in Subjects With Psychotic Major Depression (28130)(P05845)CompletedNCT00212797Phase 2
- A United States Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major DepressionCompletedNCT00208156Phase 3
- Psychological Intervention for Persons in the Early Initial Prodromal StateStatus unknownNCT00204087Phase 3
- Early Pharmacological and Psychological Intervention for Late Prodromal States of PsychosisCompletedNCT00204061Phase 4
- Indicated Prevention of Psychotic Disorders With Low-dose LithiumCompletedNCT00202306Phase 4
- Efficacy of Treating First Episode Psychosis With Folic Acid,B12 and B6 in Addition to Antipsychotic MedicationCompletedNCT00202280Phase 2/3
- Safety And Efficacy Study Of Ziprasidone In Pediatric Psychotic IllnessCompletedNCT00199940Phase 4
- From Compliance to Alliance: Engaging Psychiatric Patients in Illness ManagementStatus unknownNCT00192751Not applicable
- Dutch Prediction of Psychosis StudyStatus unknownNCT00188981
- The Immune System and Psychiatric DisordersCompletedNCT00184418
- Child Results Following Preventive Children of Parents With Psychiatric and Addictive Problems (COPP) GroupsTerminatedNCT00184405
- Effects of Psychoeducation of Relatives to Patients With Serious Mental IllnessCompletedNCT00184379Not applicable
- Secured Internet-mediated Psychotherapy With Psychiatry PatientsCompletedNCT00184340
- Changes Following Inpatient Child-oriented Family TreatmentCompletedNCT00184327
- The Effects of Different Interior Decorations in a Psychiatric Intensive Care Unit.CompletedNCT00184132Not applicable
- Effects of a Psychiatric Intensive Care UnitCompletedNCT00184119Not applicable
- The Trauma Recovery and Empowerment Model for Treating Post-Traumatic Stress Disorder in WomenCompletedNCT00183716Phase 3
- Improving Primary Care in Patients With Mental DisordersCompletedNCT00183313Phase 3
- V3: Vancouver-Victoria Valacyclovir Trial for Early PsychosisCompletedNCT00175513Phase 2
- Treatment of Depression With QuetiapineTerminatedNCT00174603Phase 3
- Treatment of Major Depressive Disorder With Psychotic Features.TerminatedNCT00174590Phase 3
- Needs Assessment of Long-Term Care for Psychiatric PatientsStatus unknownNCT00172887